
42.09BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US4055521003
CUSIP
405552100
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
18.60
PEG Ratio
2.47
Book Value
4.99
Dividend Share
0.071
Dividend Yield
0.75%
Earnings Share
0.5
Wall Street Target Price
11.81
EPS Estimate Current Year
0.56
EPS Estimate Next Year
0.61
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
11,029,999,616
Gross Profit TTM
7,144,000,000
EBITDA
2,743,000,064
Profit Margin
15.11%
Return On Assets TTM
4.67%
Return On Equity TTM
10.27%
Revenue Per Share TTM
2.456
Qtly Revenue Growth YOY
0.60%
Diluted Eps TTM
0.5
Qtly Earnings Growth YOY
92.00%
Trailing PE
18.60
Forward PE
17
Price Sales TTM
3.7474
Price Book MRQ
1.8964
Enterprise Value Revenue
3
Enterprise Value EBITDA
13
16.68
2.30%114.70
0.73%40.21
0.30%79.99
0.00%29.19
0.00%33.20
0.00%201.00
-4.66%128.12
-4.29%25.13
-3.66%35.05
-0.99%Haleon exploring sale of nicotine gum business - report